Scientists from the International Agency for Research on Cancer (IARC) and partners have shown that a new portable, low-cost, battery-powered device – a thermal ablator co-developed by IARC researchers and a team of engineers – is as effective and as safe in treating cervical precancers as current standard-of-care methods. The results, published today in Nature Medicine, are based on the largest randomized trial ever to be implemented comparing the three treatment methods.
Basu P, Mwanahamuntu M, Pinder LF, Muwonge R, Lucas E, Nyambe N, et al.
A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial
Nat Med, Published online 25 June 2024;
https://doi.org/10.1038/s41591-024-03080-w